Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 4Terminated 3Unknown 1Recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Leukemia, Myeloid, Acute 58Breast Neoplasms 54Lymphoma 52Multiple Myeloma 49Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Leukemia 48Lymphoma, Non-Hodgkin 46Melanoma 43Lymphoma, Large B-Cell, Diffuse 41Leukemia, Lymphocytic, Chronic, B-Cell 40Myelodysplastic Syndromes 39Lymphoma, Follicular 29Burkitt Lymphoma 25Hodgkin Disease 24Neoplasm Metastasis 22Recurrence 21Neoplasms 21Lymphoma, Mantle-Cell 20Lymphoma, B-Cell, Marginal Zone 18Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Ovarian Neoplasms 17Carcinoma, Non-Small-Cell Lung 17Primary Myelofibrosis 14Neoplasms, Plasma Cell 14Myeloproliferative Disorders 14Lymphoma, B-Cell 14Hematologic Neoplasms 14Leukemia, Myelomonocytic, Chronic 13Carcinoma, Renal Cell 13Triple Negative Breast Neoplasms 12

Interventions

Doxorubicin 5Cyclophosphamide 3Trastuzumab 2Docetaxel 2Dexrazoxane 2empagliflozin 1Taxes 1Tamoxifen 1Razoxane 1Radiotherapy 1Radiation 1Paclitaxel 1Neoadjuvant Therapy 1Methotrexate 1Metformin 1Leucovorin 1High-Intensity Interval Training 1Hematologic Tests 1Filgrastim 1Exercise 1Epirubicin 1Echocardiography 1Cisplatin 1Chemotherapy, Adjuvant 1Carvedilol 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Cardiotoxicity × Cyclophosphamide × Clear all
NCT01120171 2015-10-07

Myocet Plus Endoxan for Older Patients With Breast Cancer

Hellenic Oncology Research Group

Phase 2 Terminated
64 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT01301040 2013-08-30

Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

Jules Bordet Institute

Phase 2 Terminated
2 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT00016276 2013-01-16

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase 3 Terminated
396 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡